» Articles » PMID: 14555551

Clinical Risk Factors for Primary Graft Failure Following Lung Transplantation

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2003 Oct 14
PMID 14555551
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objective: s: Primary graft failure (PGF) is a devastating acute lung injury syndrome following lung transplantation. We sought to identify donor, recipient, and operative risk factors for its development.

Design: We conducted a cohort study of 255 consecutive lung transplant procedures performed between October 1991 and July 2000. We defined PGF as follows: (1) diffuse alveolar opacities exclusively involving allograft(s) and developing within 72 h of transplant, (2) a ratio of PaO(2) to fraction of inspired oxygen < 200 beyond 48 h postoperatively, and (3) no other secondary cause of graft dysfunction identified. Risk factors were assessed individually and adjusted for confounding using multivariable logistic regression models.

Setting: Tertiary-care academic medical center.

Results: The overall incidence was 11.8% (95% confidence interval [CI], 7.9 to 15.9). Following multivariable analysis, the risk factors independently associated with development of PGF were as follows: a recipient diagnosis of primary pulmonary hypertension (PPH; adjusted odds ratio [OR], 4.52; 95% CI, 1.29 to 15.9; p = 0.018), donor female gender (adjusted OR, 4.11; 95% CI, 1.17 to 14.4; p = 0.027), donor African-American race (adjusted OR, 5.56; 95% CI, 1.57 to 19.8; p = 0.008), and donor age < 21 years (adjusted OR, 4.06; 95% CI, 1.34 to 12.3; p = 0.013) and > 45 years (adjusted OR, 6.79; 95% CI, 1.61 to 28.5; p = 0.009).

Conclusions: Recipient diagnosis of PPH, donor African-American race, donor female gender, and donor age are independently and strongly associated with development of PGF.

Citing Articles

Contrasting predictors of severe primary graft dysfunction following transplant for chronic and acute respiratory failure.

Kurihara C, Kaiho T, Thomae B, Cerier E, Lung K, Avella Patino D J Thorac Dis. 2024; 16(8):5050-5062.

PMID: 39268121 PMC: 11388248. DOI: 10.21037/jtd-24-100.


Analysis of Primary Graft Dysfunction (PGD) Risk Factors in Lung Transplantation (LuTx) Patients.

Kubisa M, Wojtys M, Lisowski P, Kordykiewicz D, Piotrowska M, Wojcik J Clin Pract. 2024; 14(4):1571-1583.

PMID: 39194931 PMC: 11352894. DOI: 10.3390/clinpract14040127.


Comparison of Prognosis for Lung Transplantation between Older and Younger Donors: A Systematic Review and Meta-Analysis Based on Cohort Studies.

Di Y, Fu R, Xiang Z, Sun H, Dai M, Zhang Q Ann Thorac Cardiovasc Surg. 2024; 30(1).

PMID: 39111865 PMC: 11324350. DOI: 10.5761/atcs.ra.24-00092.


Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation.

Jenkins J, Verdiner R, Omar A, Farina J, Wilson R, DCunha J Front Immunol. 2024; 15:1341675.

PMID: 38380332 PMC: 10876853. DOI: 10.3389/fimmu.2024.1341675.


Male versus female inflammatory response after brain death model followed by ex vivo lung perfusion.

Ricardo-da-Silva F, Armstrong-Jr R, de Assis Ramos M, Vidal-Dos-Santos M, Correia C, Ottens P Biol Sex Differ. 2024; 15(1):11.

PMID: 38287395 PMC: 10826050. DOI: 10.1186/s13293-024-00581-8.